Since M2-macrophages are thought to be neuroprotective, we speculate that shifting the macrophage phenotype toward an alternative activation state may significantly increase TREM2 synthesis in AD patients and thus present a potential therapeutic avenue. The gene discussed is TREM2; the disease is Alzheimer disease.